Your Comments On...

New Safety, New Concerns In Tests for Down Syndrome

A handful of biotech companies are racing to market a new generation of tests for Down syndrome, a development that promises a safer way to spot the most common genetic cause of mental retardation early in pregnancy even as it weaves a thicket of moral, medical, political and regulatory concerns.
 - 

By Rob Stein

 
Comments
© 2009 The Washington Post Company